Clinical Reference Laboratory Gets EUA for COVID-19 Saliva Test

The FDA has granted an Emergency Use Authorization for Clinical Reference Laboratory’s (CRL) saliva-based polymerase chain reaction (PCR) COVID-19 test, CRL Rapid Response.

This test is for use with saliva specimens self-collected at home or in a healthcare setting, using the CRL COVID-19 Self-Collection Testing Kit. The company said the saliva test showed greater sensitivity and accuracy than standard nasal swab tests in clinical studies.

CRL is scaling up its testing capabilities over the next two to three weeks and looks to eventually process more than 50,000 tests a day.